NEO
NeoGenomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$17.38
−0.46%Margins
Gross margin
42.9%
EBITDA margin
1.7%
EBIT margin
-8.6%
Net margin
-6.8%
FCF margin
-1.0%
-6.6%
Return on equity
-3.8%
Return on assets
-5.4%
Return on invested capital
0.57x
Asset turnover
$22.0M
Cash from operations
$1.13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026